Analyze Diet
The veterinary quarterly2016; 36(2); 56-62; doi: 10.1080/01652176.2016.1141257

Evaluation of intra-articular injection of autologous platelet lysate (PL) in horses with osteoarthritis of the distal interphalangeal joint.

Abstract: Regenerative medicine has become one of the most promising therapies of equine osteoarthritis. Platelet lysate (PL) is rich in bioactive proteins and growth factors that play a crucial role in tissue healing. Objective: To evaluate the efficacy of intra-articularly injected autologous PL in equine athletes with naturally occurring osteoarthritis. Methods: Fifteen warmblood geldings aged 8-19 years with osteoarthritis of the distal interphalangeal joint were included in this study. They were randomly divided into two groups; 10 horses received intra-articular injections of PL and 5 of normal saline (controls). Before treatment, platelet-derived growth factor (PDGF) levels in basal plasma and prepared PL were estimated. Each joint was injected twice within a three-week period. Lameness was evaluated using the American Association of Equine Practitioners grading system, before treatment and 10 days after each intra-articular injection. Horses were examined fortnightly for one year. Radiographic examination was performed six months post-treatment. The generalized estimating equation test was used for statistical analysis. Results: Acceptable levels of PDGF were detected in PLs (mean ± SD: 258.0 ± 52.3 pg/ml). The majority of horses (9/10) responded positively to PL treatment presenting lower lameness grades (p < 0.0005) compared to controls 10 days after the second injection, and returned to normal athletic activity. Radiographs revealed no changes in osteoarthritis lesions six months after treatment. One year post-injections, however, all horses relapsed to their initial degree of lameness. Conclusions: Intra-articularly injected autologous PL is an efficient method for temporarily managing osteoarthritis of the distal interphalangeal joint in athletic horses.
Publication Date: 2016-02-01 PubMed ID: 26828234DOI: 10.1080/01652176.2016.1141257Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article
  • Randomized Controlled Trial

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

This research study investigated the use of platelet lysate (PL), a product rich in bioactive proteins and growth factors, in treating osteoarthritis in horses. Researchers found that PL injections helped reduce lameness in horses with osteoarthritis, however, the effect was only temporary and symptoms returned a year after treatment.

Research Methodology

  • The study included fifteen warmblood geldings, a type of horse breed, aged between 8 to 19 years, all suffering from osteoarthritis of the distal interphalangeal joint.
  • The horses were split into two teams: Ten horses received intra-articular injections of platelet lysate (PL), and the remaining five horses were administered normal saline injections as a control group.
  • The researchers evaluated the levels of platelet-derived growth factor (PDGF), a protein that aids in cell growth and division, in both the basal plasma and prepared PL before treatment.
  • Each horse’s affected joint was injected two times during a period of three weeks.
  • The researchers measured lameness—the horse’s condition causing irregularity in movement—using a grading system developed by the American Association of Equine Practitioners, both before treatment and ten days after each injection.
  • All horses were examined every two weeks for one year after the injections.
  • Radiographic examinations—medical imaging procedures using X-rays—were undertaken six months after the treatment.

Research Findings

  • PLs were found to contain acceptable levels of PDGF, indicating the potential to support tissue healing.
  • Majority of horses (9 out of 10) showed a positive response to the PL treatment, indicated by lower lameness grades compared to the control group. The improvement was observed ten days after the second injection.
  • These horses were able to return to normal athletic activity post-treatment.
  • Radiographs taken six months post-treatment revealed no changes in osteoarthritis lesions, confirming that the intra-articular PL injections did not impact the physical signs of the disease but did manage the symptoms.
  • A downside to this treatment was found, however, when all horses returned to their initial degree of lameness one year post-injections, indicating that the benefits of PL injections were only temporary.

Conclusion

  • The study concluded that using PL through intra-articular injections is an effective temporary solution to manage the symptoms of osteoarthritis in horses, especially concerning lameness.
  • This suggests that while PL might not cure or reverse osteoarthritis, it can provide temporary relief for the horses, improving their quality of life and athletic performance.

Cite This Article

APA
Tyrnenopoulou P, Diakakis N, Karayannopoulou M, Savvas I, Koliakos G. (2016). Evaluation of intra-articular injection of autologous platelet lysate (PL) in horses with osteoarthritis of the distal interphalangeal joint. Vet Q, 36(2), 56-62. https://doi.org/10.1080/01652176.2016.1141257

Publication

ISSN: 1875-5941
NlmUniqueID: 7909485
Country: England
Language: English
Volume: 36
Issue: 2
Pages: 56-62

Researcher Affiliations

Tyrnenopoulou, Panagiota
  • a Equine Unit, Companion Animal Clinic, Department of Clinical Studies, School of Veterinary Medicine, Faculty of Health Sciences , Aristotle University of Thessaloniki , Thessaloniki , Greece.
Diakakis, Nikolaos
  • a Equine Unit, Companion Animal Clinic, Department of Clinical Studies, School of Veterinary Medicine, Faculty of Health Sciences , Aristotle University of Thessaloniki , Thessaloniki , Greece.
Karayannopoulou, Maria
  • b Surgery and Obstetrics Unit, Companion Animal Clinic, Department of Clinical Studies, School of Veterinary Medicine, Faculty of Health Sciences , Aristotle University of Thessaloniki , Thessaloniki , Greece.
Savvas, Ioannis
  • c Anaesthesiology and Intensive Care Unit, Companion Animal Clinic, Department of Clinical Studies, School of Veterinary Medicine, Faculty of Health Sciences , Aristotle University of Thessaloniki , Thessaloniki , Greece.
Koliakos, Georgios
  • d Department of Biochemistry, Medical School , Faculty of Health Sciences , Aristotle University of Thessaloniki , Thessaloniki , Greece.

MeSH Terms

  • Animals
  • Blood Platelets / physiology
  • Carpal Joints / physiopathology
  • Forelimb / physiopathology
  • Horse Diseases / etiology
  • Horse Diseases / therapy
  • Horses
  • Injections, Intra-Articular / veterinary
  • Male
  • Osteoarthritis / etiology
  • Osteoarthritis / therapy
  • Osteoarthritis / veterinary

Citations

This article has been cited 22 times.
  1. Moellerberndt J, Hagen A, Niebert S, Büttner K, Burk J. Cytokines in equine platelet lysate and related blood products. Front Vet Sci 2023;10:1117829.
    doi: 10.3389/fvets.2023.1117829pubmed: 36968472google scholar: lookup
  2. Mayet A, Zablotski Y, Roth SP, Brehm W, Troillet A. Systematic review and meta-analysis of positive long-term effects after intra-articular administration of orthobiologic therapeutics in horses with naturally occurring osteoarthritis. Front Vet Sci 2023;10:1125695.
    doi: 10.3389/fvets.2023.1125695pubmed: 36908512google scholar: lookup
  3. Pezzanite LM, Chow L, Griffenhagen GM, Bass L, Goodrich LR, Impastato R, Dow S. Distinct differences in immunological properties of equine orthobiologics revealed by functional and transcriptomic analysis using an activated macrophage readout system. Front Vet Sci 2023;10:1109473.
    doi: 10.3389/fvets.2023.1109473pubmed: 36876001google scholar: lookup
  4. Troha K, Vozel D, Arko M, Bedina Zavec A, Dolinar D, Hočevar M, Jan Z, Kisovec M, Kocjančič B, Pađen L, Pajnič M, Penič S, Romolo A, Repar N, Spasovski V, Steiner N, Šuštar V, Iglič A, Drobne D, Kogej K, Battelino S, Kralj-Iglič V. Autologous Platelet and Extracellular Vesicle-Rich Plasma as Therapeutic Fluid: A Review. Int J Mol Sci 2023 Feb 8;24(4).
    doi: 10.3390/ijms24043420pubmed: 36834843google scholar: lookup
  5. Frias-De-Diego A, Gilbertie JM, Scholle F, Dejarnette S, Crisci E. Effect of BIO-PLY(TM), a Platelet-Rich Plasma Derived Biologic on PRRSV-2-Infected Macrophages. Viruses 2022 Nov 28;14(12).
    doi: 10.3390/v14122666pubmed: 36560670google scholar: lookup
  6. Hagen A, Holland H, Brandt VP, Doll CU, Häußler TC, Melzer M, Moellerberndt J, Lehmann H, Burk J. Platelet Lysate for Mesenchymal Stromal Cell Culture in the Canine and Equine Species: Analogous but Not the Same. Animals (Basel) 2022 Jan 13;12(2).
    doi: 10.3390/ani12020189pubmed: 35049811google scholar: lookup
  7. Boffa A, Salerno M, Merli G, De Girolamo L, Laver L, Magalon J, Sánchez M, Tischer T, Filardo G. Platelet-rich plasma injections induce disease-modifying effects in the treatment of osteoarthritis in animal models. Knee Surg Sports Traumatol Arthrosc 2021 Dec;29(12):4100-4121.
    doi: 10.1007/s00167-021-06659-9pubmed: 34341845google scholar: lookup
  8. De Angelis E, Saleri R, Martelli P, Elviri L, Bianchera A, Bergonzi C, Pirola M, Romeo R, Andrani M, Cavalli V, Conti V, Bettini R, Passeri B, Ravanetti F, Borghetti P. Cultured Horse Articular Chondrocytes in 3D-Printed Chitosan Scaffold With Hyaluronic Acid and Platelet Lysate. Front Vet Sci 2021;8:671776.
    doi: 10.3389/fvets.2021.671776pubmed: 34322533google scholar: lookup
  9. Segabinazzi LGTM, Podico G, Rosser MF, Nanjappa SG, Alvarenga MA, Canisso IF. Three Manual Noncommercial Methods to Prepare Equine Platelet-Rich Plasma. Animals (Basel) 2021 May 21;11(6).
    doi: 10.3390/ani11061478pubmed: 34063777google scholar: lookup
  10. Camargo Garbin L, Lopez C, Carmona JU. A Critical Overview of the Use of Platelet-Rich Plasma in Equine Medicine Over the Last Decade. Front Vet Sci 2021;8:641818.
    doi: 10.3389/fvets.2021.641818pubmed: 33869321google scholar: lookup
  11. Ribitsch I, Oreff GL, Jenner F. Regenerative Medicine for Equine Musculoskeletal Diseases. Animals (Basel) 2021 Jan 19;11(1).
    doi: 10.3390/ani11010234pubmed: 33477808google scholar: lookup
  12. Gilbertie JM, Schaer TP, Schubert AG, Jacob ME, Menegatti S, Ashton Lavoie R, Schnabel LV. Platelet-rich plasma lysate displays antibiofilm properties and restores antimicrobial activity against synovial fluid biofilms in vitro. J Orthop Res 2020 Jun;38(6):1365-1374.
    doi: 10.1002/jor.24584pubmed: 31922274google scholar: lookup
  13. Yan L, Zhou L, Xie D, Du W, Chen F, Yuan Q, Tong P, Shan L, Efferth T. Chondroprotective effects of platelet lysate towards monoiodoacetate-induced arthritis by suppression of TNF-α-induced activation of NF-ĸB pathway in chondrocytes. Aging (Albany NY) 2019 May 14;11(9):2797-2811.
    doi: 10.18632/aging.101952pubmed: 31089001google scholar: lookup
  14. Linardi RL, Dodson ME, Moss KL, King WJ, Ortved KF. The Effect of Autologous Protein Solution on the Inflammatory Cascade in Stimulated Equine Chondrocytes. Front Vet Sci 2019;6:64.
    doi: 10.3389/fvets.2019.00064pubmed: 30895181google scholar: lookup
  15. Gilbertie JM, Long JM, Schubert AG, Berglund AK, Schaer TP, Schnabel LV. Pooled Platelet-Rich Plasma Lysate Therapy Increases Synoviocyte Proliferation and Hyaluronic Acid Production While Protecting Chondrocytes From Synoviocyte-Derived Inflammatory Mediators. Front Vet Sci 2018;5:150.
    doi: 10.3389/fvets.2018.00150pubmed: 30023361google scholar: lookup
  16. Bogers SH. Cell-Based Therapies for Joint Disease in Veterinary Medicine: What We Have Learned and What We Need to Know. Front Vet Sci 2018;5:70.
    doi: 10.3389/fvets.2018.00070pubmed: 29713634google scholar: lookup
  17. Hassan G, Bahjat M, Kasem I, Soukkarieh C, Aljamali M. Platelet lysate induces chondrogenic differentiation of umbilical cord-derived mesenchymal stem cells. Cell Mol Biol Lett 2018;23:11.
    doi: 10.1186/s11658-018-0080-6pubmed: 29568314google scholar: lookup
  18. Carmona JU, Ríos DL, López C, Álvarez ME, Pérez JE. Proinflammatory and Anabolic Gene Expression Effects of Platelet-Rich Gel Supernatants on Equine Synovial Membrane Explants Challenged with Lipopolysaccharide. Vet Med Int 2017;2017:6059485.
    doi: 10.1155/2017/6059485pubmed: 28761774google scholar: lookup
  19. Kooy S, Constant J, Cole R, Boone L. Safety study of leucoreduced allogeneic pooled freeze-dried platelet-rich plasma in healthy equine joints. Front Vet Sci 2025;12:1625431.
    doi: 10.3389/fvets.2025.1625431pubmed: 40727274google scholar: lookup
  20. Guidoni K, Chiaradia E, Pepe M, Di Meo A, Tognoloni A, Seccaroni M, Beccati F. The Combined Use of Triamcinolone and Platelet-Rich Plasma in Equine Metacarpophalangeal Joint Osteoarthritis Treatments: An In Vivo and In Vitro Study. Animals (Basel) 2024 Dec 17;14(24).
    doi: 10.3390/ani14243645pubmed: 39765549google scholar: lookup
  21. Carmona JU, Carmona-Ramírez LH, López C. Platelet-Rich Plasma and Related Orthobiologics for the Treatment of Equine Musculoskeletal Disorders-A Bibliometric Analysis from 2000 to 2024. Vet Sci 2024 Aug 21;11(8).
    doi: 10.3390/vetsci11080385pubmed: 39195839google scholar: lookup
  22. Valtetsiotis K, Di Martino A, Brunello M, D'Agostino C, Poluzzi R, Ferri R, Mora P, Traina F, Faldini C. Platelet lysate for the treatment of osteoarthritis: a systematic review of preclinical and clinical studies. Musculoskelet Surg 2024 Sep;108(3):275-288.
    doi: 10.1007/s12306-024-00827-zpubmed: 38829480google scholar: lookup